F17L (p.Phe17Leu) variant of AQP2 (Aquaporin-2)

F17L (p.Phe17Leu) in AQP2 (Aquaporin-2) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.66 / 1. The record also includes population frequency data and structural context.

F17L (p.Phe17Leu) variant details